similarly, the effects of AICAR on cholesterol efflux from INS-1 cells were reversed by PARP-1 (Figure 4E)
AANA developed policies and procedures that align with best available evidence for treating patients taking GLP-1 receptor agonists, which increase insulin synthesis and secretion, suppress glucagon secretion, reduce food intake through appetite suppression, slow gastric emptying, and promote beta-cell proliferation
According to StatPearls, GLP-1 receptor agonists stimulate insulin secretion and lower glucagon in a glucose-dependent way, supporting weight loss while helping prevent hypoglycemia How Much Weight Can You Lose In A Month On GLP-1
After weighting the cohorts for inverse probability of treatment, the researchers found that, compared with second-line GLDs, ADRD risk was significantly lower with both GLP-1 receptor agonists (adjusted HR = 0.67
The FDA recently approved versions of GLP-1 medication - including Wegovy (semaglutide), Saxenda (liraglutide), and Zepbound (tirzepatide) - for chronic weight management
